Good News For Medtech Regulation In The EU As Turkxit Is Avoided
Turkey and the EU have avoided the equivalent of a Brexit, or Swixit. Medtech trade will continue unhindered now it has been established that the EU/Turkey Customs Union will remain.
You may also be interested in...
One Hurdle After Another: Safely Aligned With EU MDR, Turkish Medtechs Brace For New Efforts On Domestic Front
Alignment with the MDR gave Turkish medtech access to the EU market, but in domestic pricing, costs, reimbursement and payment of hospital debts, industry might feel it is barely at the starting line.
The EU’s Competent Authorities for Medical Devices group has been meeting with the Heads of Medicines Agencies to discuss more collaborative work on borderline and combination products.
Mindful of the different information needs of patients and health care professionals when reading implant cards, the European Commission has issued new guidance.